Greg Mulholland – 2015 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Greg Mulholland on 2015-12-14.

To ask the Secretary of State for Health, what discussions Solutions for Public Health has had with the European Medicines Agency and US Food and Drug Administration on developing a draft commissioning policy for everolimus.

George Freeman

Solutions for Public Health has confirmed that they have not had any discussions with either the European Medicines Agency or US Food and Drug Administration in relation to Everolimus.

This is outside of the scope of the evidence review methodology commissioned by NHS England and would not be relevant to their role as a provider of stand-alone clinical evidence reviews.